Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis

Ronald A. Lubet, Eva Szabo, Kenneth K. Iwata, Stanley C. Gill, Chris Tucker, Ann Bode, Vernon E. Steele, M. Margaret Juliana, Holly L. Nicastro, Clinton J. Grubbs

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis'. Together they form a unique fingerprint.

Medicine & Life Sciences